CARIS LIFE SCIENCES INC (CAI) Stock Analyst Ratings
USA - NASDAQ:CAI - US1421521071 - Common Stock
31.78 USD
+2.07 (+6.97%)
31.77 USD
-0.01 (-0.03%)
ChartMill assigns a Buy % Consensus number of 87% to CAI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.91. This target is 25.57% above the current price.
CAI was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CAI.
In the previous month the buy percentage consensus was at a similar level.
CAI was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-13 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-13 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-15 | Evercore ISI Group | Initiate | Outperform |
| 2025-07-14 | TD Cowen | Initiate | Buy |
| 2025-07-14 | Guggenheim | Initiate | Buy |
| 2025-07-14 | Wolfe Research | Initiate | Outperform |
| 2025-07-14 | JP Morgan | Initiate | Overweight |
| 2025-07-14 | Citigroup | Initiate | Buy |
| 2021-06-30 | Keefe, Bruyette & Woods | Downgrade | Outperform -> Market Perform |
| 2021-06-21 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-06-18 | B. Riley Securities | Downgrade | Buy -> Neutral |